Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Phase I findings support advancement of CI-1023 to phase II evaluation

Nov. 13, 2001

SOD mimetic protects cardiac allografts from ischemia-reperfusion injury

Nov. 13, 2001

Alteon commences phase I testing of ALT-711 in ESRD patients undergoing peritoneal dialysis

Nov. 12, 2001

Further subgroup analyses of PROWESS data presented at Chest 2001

Nov. 9, 2001

Adenosine modulation by pentostatin shows beneficial effects in septic mice

Nov. 9, 2001

Prostaglandin derivatives with binding affinity for EP receptors and use thereof

Nov. 8, 2001

Abgenix licenses rights to human antiproperdin monoclonal antibodies

Nov. 8, 2001

Lilly receives approvable letter from FDA for Xigris

Nov. 6, 2001

Sanofi-Synthelabo describes novel V1-selective agents and their use

Oct. 29, 2001

New series synthesized at Bayer shows inhibitory activity against cGMP-PDE

Oct. 26, 2001

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...